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6ABSTRACT
Introduction: The Osteogenesis Imperfecta (OI) is a group of 
hereditary disorders that occurs due to a deficiency in the 
production of collagen type I. Aim: The aim of this study is 
to report a case of a male patient, four years of age 
diagnosed with OI type V and the care that must be taken in 
the dental care. Case report: The mother reported that the 
child had already suffered several bone fractures and 
currently was with the use of calcium carbonate, D vitamin and 
pamidronate. The proposed intervention was control of dental 
biofilm with professional prophylaxis, due to the 
uncooperative behavior was employed the active protective 
stabilization technique and mouth opener. Conclusion: It was 
concluded that due to bone fragility and risk of fractures is 
important to the careful positioning of the patient in the 
dental chair, correct use of auxiliary devices and basics and
advanced techniques of behavior management.
7INTRODUCTION
Osteogenesis imperfecta (OI) is a disease clinically and 
genetically de group of heritable disorders of connective
tissue.1 It is a rare disease, whose most common inheritance is 
autossomic dominant, caused by mutations in the collagen type 
I alphal (COL1A1) or collagen type I alpha2 (COL1A2) genes
associated with type I collagen metabolism changes. This
change was classified into four main groups according to their 
clinical characteristics and pattern of genetic inheritance: 
type I, type II, type III and type IV. Subsequently, Glorieux 
et al (2000)4 expanded the classification including the types
V, VI and VII. The prevalence of OI is estimated at 1 in 
10.000 new births.5
The OI offers secondary characteristics important general 
that characterize the different types of the disease.1 In 
addition, this aberration may also display characteristics 
craniofacial and oral health, such as modification of 
craniofacial growth, malocclusion of Class III crossbite, 
anterior and/or posterior and anterior open later6 and 
dentinogenesis imperfecta type I, which is reported to be
o
higher in deciduous teeth. However the most striking feature 
is the bone fragility, with the tendency to fracture from 
minimal trauma, which leads this change to be known as Brittle 
Bone Disease.1
8In dental care of children and patients with disabilities 
the stabilization cases may be used, however observing some 
aspects first, such as the need of the patient receiving 
diagnosis and immediate treatment, ensuring the safety of the 
patient, professional and team.9 The bone fragility presented 
in OI can be considered a risk at the time of implementation 
of the protective stabilization. Therefore, the objective of 
this study was to report the clinical case of a patient with 
OI type V and describe the dental approach regarding the use 
of protective stabilization.
CASE DESCRIPTION
A male patient with four years of age is monitored with a 
multidisciplinary team composed by Pediatric Dentistry, Nurse 
and Nutritionist in the Special Patients, Hospital Dentistry 
at the Federal University of Uberlândia (SEPAE-UFU) since a 
month of life, having been held twelve dental consultations 
for follow-up.
Anamnesis
The mother revealed that there were no complications 
during pregnancy, but the same reports have been submitted to 
an ultrasound and radiographic examination, in which were
highlighted some intra-uterus in the leg and ribs of the baby,
9but without the confirmation of the diagnosis of OI. The child
was born at 39 weeks, by means of childbirth cesarean type.
The child was born weighing 2,515 g and measuring 45
centimeters.
The seven days of life was the diagnosis of OI type V,
where they were found fractures of the two arms, two legs,
clavicle and rib, by means of radiographic examination, the 
child was then immobilized only with a chamois to healing. The 
two months of life the patient suffered a fracture in his leg 
during the vaccination. At 10 months of life had a fracture of 
the femur being needed sedation was required for the limb to 
be cast, since then the patient has not suffered any bone 
fracture.
Currently, the patient is under treatment and medical 
follow-up with a pediatrician and geneticist, makes use of 
calcium carbonate, 7 ml per day and D vitamin, 5 drops 
per day, both medications are in use since the eight months of 
age. In addition, the patient also makes use of intravenous 
pamidronate a year ago, a type of bisphosphonate used in the 
treatment of bone mineral density. This medication is 
administered in a Hospital of Clinics of Federal University of 
Uberlândia at intervals of four months and children need to 
be admitted under observation during three days, because it is
given in three doses.
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Extraoral and Intraoral Clinical examination
The clinical examination extraoral was observed skeletal 
changes, such as the shape of the face triangular, frontal 
bone prominent, a cephalic perimeter of 30 cm and absence of 
bluish sclera (Figure 1). The intraoral clinical
examination the child presented the deciduous dentition 
complete, without change in shape and number of teeth and 
absence of dentinogenesis imperfecta (DI). Oral hygiene was 
regular, with the presence of dental biofilm visible, but 
absence of dental caries (Figure 2).
Dental Approach
The first dental visit happened with a month of age, 
where information was provided regarding oral hygiene and 
diet. The patient is monitored at regular dental treatment 
every four months for the control of dental biofilm. The 
dental approach is strictly a preventive, acting in control of 
biofilm, with professional prophylaxis, using Robinson 
toothbrush and prophylactic folder and use of dental floss. 
Furthermore, the strengthening and encouraging oral hygiene at 
home with toothbrush and toothpaste, as well as the use of 
dental floss (Figure 3).
Throughout the entire monitoring dental, the techniques 
of managing basic behavioral were used with the objective to
familiarize the child with the dental environment. Despite the
11
use of these practices often the patient still presents a 
behavior does not associate, being necessary the use of 
management technique advanced behavioral type active
protective stabilization with the mother holding his arms and 
legs of the child (Figure 4). Thus, the mother received the 
guidelines about and justifications for the use of this 
technique, agreeing, in writing in its use. In addition to the
active protective stabilization, it was necessary to the
careful use of mouth opener for the achievement of
professional prophylaxis and the diagnosis of possible dental 
abnormalities (Figure 5).
DISCUSSION
The OI type V is an extremely rare disease caused by a 
mutation in the gene IFITM5 and that presents a great 
phenotypic variability.10 This gene is responsible for encoding 
the protein BRIL, which is considered a marker of Mineralizing 
osteoblasts.11 This study presented a case report of a child 
diagnosed very early with OI type V, despite its hereditary, 
there is a report in the family of another person with the 
same anomaly. OI type V does not present some classic features 
such as, for example, the bluish sclera.1
The intrauterine fracture is a finding is extremely rare,
but can occur in certain situations such as the OI. The
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ultrasound and radiographic examination should be used for the 
diagnosis of possible fractures of any etiology and the choice 
of delivery, the biochemical tests and genetic factors may be 
specific to assist in prenatal diagnosis of OI. The choice of 
delivery is especially important when there is a risk to the 
mother or the baby, and the cesarean delivery type more 
suitable. In the present report was detected intra-uterus, by 
means of imaging examinations. However, despite the advances 
in diagnosis of OI, the tests required for the early diagnosis 
were not performed during the prenatal period, but 
fortunately, the birth cesarean type was chosen, and 
the diagnosis occurred only after 7 days of life.
The pharmacological treatment of OI has been performed 
with the use of bisphophonates, current evidence shows that 
this medicine orally or intravenously is able to increase bone 
mineral density. The patient reported here makes periodic use 
of intravenous pamidronate, a year ago, a type 
of bisphosphonate, for increasing the density. Pamidronate has 
been effective in the treatment of OI, and your success does 
not seem to be related to the change in genotype of type I 
collagen in patients with OI.14
Regard the oral condition, the patient had no dental 
alterations or dentinogenesis imperfecta, since this is not a 
common feature of OI type V.1 In addition, the clinical
13
examination also not diagnosed with lesions of caries, which 
can be explained by the dental care early, before the first 
year of life, and the child is accompanied by specialized 
staff, periodically in accordance with the risk assessment 
with dental caries.
Although the patient receive a follow-up regular dental 
care, since an age very early and have their behavior managed 
through basic techniques, it still retains a little behavior 
collaborator during the dental consultations, even for the 
achievement of preventive procedures. Therefore, it 
is necessary to use the protective stabilization activates 
with an adult by restricting the movement of members. This 
method is considered to be safe and indicated in patients who 
need dental care and that for reasons of little development 
and maturity or lack of ability to understand, they 
cannot collaborate with the attendant.9
However, patients who have a bone fragility exacerbated 
as at OI, the method may present a high risk of bone fracture, 
when not performed safely and properly. That is why the 
participation of parents during the completion of 
stabilization is indispensable, since they have greater 
experience and possibly have already received medical 
information about the best way of positioning and handling of
the child in specific situations.
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Other arrangements necessary for the implementation of 
dental care in the abovementioned patient was the opener of 
mouth. Although this device can be used to enable and maintain 
the mouth opening, the use of this device in children not 
collaborator is not considered as protective stabilization.9 
However, for the use of the device it is necessary to perform 
the mouth opening of the child, often non-voluntarily, and 
this procedure in a patient with OI can generate serious 
disorders such as the risk of occurrence of bone fractures. 
Therefore, further information must be disseminated in order 
to prevent the risk of bone fractures during dental care in 
patients with OI.
CONCLUSIONS
It was concluded that OI presents great bone fragility and 
fracture risks, so the adequate and safe positioning of the 
patient in the dental chair, as well as the correct use of 
auxiliary devices such as mouth openers should be evaluated 
frequently during the care dental practice. Basic behavioral 
management techniques should be encouraged because they have 
satisfactory success rates. On the other hand, advanced 
behavioral management techniques, such as protective 
stabilization, can be indicated, but performed in a cautious
way with the participation of the family. Thus, they become
15
important preventive procedures for the maintenance of oral 
health, avoiding curative care that requires longer 
intervention time and more invasive procedures.
16
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Figure 1. A and B - Skeletal changes, such as the shape of the 
face triangular, frontal bone prominent, a cephalic perimeter 
of 30 cm. C - Absence of bluish sclera.
Figure 2. A - The present the deciduous dentition complete, 
without change in shape and number of teeth and absence of 
dentinogenesis imperfecta. B - Oral hygiene was regular, with 
the presence of dental biofilm visible, but absence of 
dental caries.
Figure 3. A, B and C - The strengthening and encouraging oral 
hygiene at home with toothbrush and toothpaste. D - Incentive 
the use of dental floss.
Figure 4. Need to use of management technique advanced 
behavioral type active protective stabilization with the 
mother holding his arms and legs of the child.
Figure 5. Need to use of mouth opener for the achievement of 
professional prophylaxis and the diagnosis of possible dental 
abnormalities.
Figure legends
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